-DOCSTART- -X- O
Since -X- _ O
their -X- _ O
discovery -X- _ O
as -X- _ O
a -X- _ O
tool -X- _ O
for -X- _ O
gene -X- _ O
transfer -X- _ O
, -X- _ O
vectors -X- _ B-Intervention
derived -X- _ I-Intervention
from -X- _ I-Intervention
the -X- _ I-Intervention
adeno-associated -X- _ I-Intervention
virus -X- _ I-Intervention
( -X- _ I-Intervention
AAV -X- _ I-Intervention
) -X- _ I-Intervention
have -X- _ O
been -X- _ O
used -X- _ O
for -X- _ O
gene -X- _ O
therapy -X- _ O
applications -X- _ O
and -X- _ O
attracted -X- _ O
scientist -X- _ O
to -X- _ O
this -X- _ O
field -X- _ O
for -X- _ O
their -X- _ O
exceptional -X- _ O
properties -X- _ O
of -X- _ O
efficiency -X- _ O
of -X- _ O
in -X- _ O
vivo -X- _ O
gene -X- _ O
transfer -X- _ O
and -X- _ O
the -X- _ O
level -X- _ O
and -X- _ O
duration -X- _ O
of -X- _ O
transgene -X- _ O
expression. -X- _ O
For -X- _ O
many -X- _ O
years -X- _ O
, -X- _ O
AAVs -X- _ B-Intervention
have -X- _ O
been -X- _ O
considered -X- _ O
as -X- _ O
low -X- _ O
immunogenic -X- _ O
vectors -X- _ O
due -X- _ O
to -X- _ O
their -X- _ O
ability -X- _ O
to -X- _ O
induce -X- _ O
long-term -X- _ O
expression -X- _ O
of -X- _ O
non-self-proteins -X- _ O
in -X- _ O
contrast -X- _ O
to -X- _ O
what -X- _ O
has -X- _ O
been -X- _ O
observed -X- _ O
with -X- _ O
other -X- _ O
viral -X- _ O
vectors -X- _ O
, -X- _ O
such -X- _ O
as -X- _ O
adenovirus -X- _ O
, -X- _ O
for -X- _ O
which -X- _ O
strong -X- _ O
immune -X- _ O
responses -X- _ O
against -X- _ O
the -X- _ O
same -X- _ O
transgene -X- _ O
products -X- _ O
were -X- _ O
documented. -X- _ O
The -X- _ O
perceived -X- _ O
low -X- _ O
immunogenicity -X- _ O
likely -X- _ O
explains -X- _ O
why -X- _ O
the -X- _ O
use -X- _ O
of -X- _ O
AAV -X- _ B-Intervention
vectors -X- _ I-Intervention
for -X- _ I-Intervention
vaccination -X- _ I-Intervention
was -X- _ O
not -X- _ O
seriously -X- _ O
considered -X- _ O
before -X- _ O
the -X- _ O
early -X- _ O
2000s. -X- _ O
Indeed -X- _ O
, -X- _ O
while -X- _ O
analyses -X- _ O
conducted -X- _ O
using -X- _ O
a -X- _ O
variety -X- _ O
of -X- _ O
transgenes -X- _ O
and -X- _ O
animal -X- _ O
species -X- _ O
slowly -X- _ O
changed -X- _ O
the -X- _ O
vision -X- _ O
of -X- _ O
immunological -X- _ O
properties -X- _ O
of -X- _ O
AAVs -X- _ B-Intervention
, -X- _ O
an -X- _ O
increasing -X- _ O
number -X- _ O
of -X- _ O
studies -X- _ O
were -X- _ O
also -X- _ O
performed -X- _ O
in -X- _ O
the -X- _ O
field -X- _ O
of -X- _ O
vaccination. -X- _ O
Even -X- _ O
if -X- _ O
the -X- _ O
comparison -X- _ O
with -X- _ O
other -X- _ O
modes -X- _ O
of -X- _ O
vaccination -X- _ O
was -X- _ O
not -X- _ O
systemically -X- _ O
performed -X- _ O
, -X- _ O
the -X- _ O
analyses -X- _ O
conducted -X- _ O
so -X- _ O
far -X- _ O
in -X- _ O
the -X- _ O
field -X- _ O
of -X- _ O
active -X- _ O
immunotherapy -X- _ O
strongly -X- _ O
suggest -X- _ O
that -X- _ O
AAVs -X- _ B-Intervention
possess -X- _ O
some -X- _ O
interesting -X- _ O
features -X- _ O
to -X- _ O
be -X- _ O
used -X- _ O
as -X- _ O
tools -X- _ O
to -X- _ O
produce -X- _ O
an -X- _ O
efficient -X- _ O
and -X- _ O
sustained -X- _ O
antibody -X- _ O
response. -X- _ O
In -X- _ O
addition -X- _ O
, -X- _ O
recent -X- _ O
studies -X- _ O
also -X- _ O
highlighted -X- _ O
the -X- _ O
potential -X- _ O
of -X- _ O
AAVs -X- _ O
for -X- _ O
passive -X- _ O
immunotherapy. -X- _ O
This -X- _ O
review -X- _ O
summarizes -X- _ O
the -X- _ O
main -X- _ O
studies -X- _ O
conducted -X- _ O
to -X- _ O
evaluate -X- _ O
the -X- _ O
potential -X- _ O
of -X- _ O
AAV -X- _ B-Intervention
vectors -X- _ I-Intervention
for -X- _ I-Intervention
vaccination -X- _ I-Intervention
against -X- _ O
infectious -X- _ B-Patient
agents -X- _ I-Patient
and -X- _ O
discusses -X- _ O
their -X- _ O
advantages -X- _ O
and -X- _ O
drawbacks. -X- _ O
Altogether -X- _ O
, -X- _ O
the -X- _ O
variety -X- _ O
of -X- _ O
studies -X- _ O
conducted -X- _ O
in -X- _ O
this -X- _ O
field -X- _ O
contributes -X- _ O
to -X- _ O
the -X- _ O
understanding -X- _ O
of -X- _ O
the -X- _ O
immunological -X- _ O
properties -X- _ O
of -X- _ O
this -X- _ O
versatile -X- _ O
virus -X- _ O
and -X- _ O
to -X- _ O
the -X- _ O
definition -X- _ O
of -X- _ O
its -X- _ O
possible -X- _ O
future -X- _ O
applications -X- _ O
. -X- _ O

